Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Hong Kong's Nan Fung Leads $45 Million Round for US Hearing Device Maker

publication date: Oct 20, 2017

Eargo, a Silicon Valley direct-to-consumer hearing aid company, closed the first tranche of a $45 million Series C round, led by Hong Kong's Nan Fung Life Sciences Fund. The round included investors New Enterprise Associates, Charles and Helen Schwab, and Maveron. Eargo makes a small, nearly invisible hearing aid that it says is comfortable and rechargeable. The device, which costs just under $2,000 per pair, is a Class I, FDA-regulated product. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events


China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020